Skip to content

Dr Capucine Verstraete

Active Private limited companyfounded 2023active for 3 yearsJules Van Biesbroeckstraat 2, 9050 GhentKBO/BCE: BE 0798.843.401

Lifetime

3 annual accounts with figures on one time axis
peak of €152,981 in 2025
€152,981▲ 21.5%
peak of €100,798 in 2025
€100,798▲ 22.1%
peak of €257,132 in 2025
€257,132▲ 64.5%
€17,946▲ 12.6%
Board1 name since 2023
1 director
Documentsfilings and deeds
17-06-202644 days before the deadline
2025micro format
Gross margin from €125,930 to €152,981Equity from €156,335 to €257,132Cash from €108,133 to €210,194

Key points

from the 2025 annual accounts

Equity

€257,132 ▲ 64.5%
€156,0002024€257,0002025

Equity rose in 2025 from €156,335 to €257,132.

Liquidity

14.82 was 9.53 in 2024

Short-term debts rose from €15,344 to €17,346.

Position in the sector

93.5%

Higher solvency than 93% of companies in real estate. The sector median is 31.0%, over 19,873 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Dr Capucine Verstraete has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Dr Capucine Verstraete. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 23-02-2023
  • founderdeed of 28-02-2023
Board & ownership

Recent changes

Incorporation Founded by · 100 shares · appointed as director · published on 28-02-2023 · Gazette deed
First establishment Jules Van Biesbroeckstraat 2, Ghent
All 9 events

Comparable companies

same main activity, similar in size and age
Company
Dr Capucine Verstraete Ghent €275,078 €152,981 93.5% -
MANAGEMENT GERARD DEBOUCHE Seneffe €288,366 €135,888 49.6% -
Ladivi Vosselaar €234,840 €142,023 91.0% -
GERI Edegem €277,388 €98,364 94.3% -
We Invest Dilbeek Dilbeek €200,042 €116,886 61.7% -
SHEREK INVEST Waremme €295,656 €104,817 70.9% -
G2-IMMO Soumagne €180,741 €149,222 70.6% -

These companies have the same main activity as Dr Capucine Verstraete: renting and operating of own or leased residential real estate, excluding social housing (NACE 68201). They are comparable in size and age: total assets between €181,000 and €296,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 24-02-2023Normal situation
Activity
Renting and operating of own or leased residential real estate, excluding social housingNACE 68201
Establishment unit
2.345.129.2109050 Ghent, since 24-02-2023
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €220,000estimated
€275,078▲ 59.7%
Filing
Filed on 17-06-2026, 44 days before the end of the filing period
Financials

Insights on Dr Capucine Verstraete

Dr Capucine Verstraete files the micro format. That format states no turnover. The gross margin rose from €107,051 in 2023 to €152,981 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr Capucine Verstraete

What is the company number of Dr Capucine Verstraete?
The company number of Dr Capucine Verstraete is 0798.843.401. The VAT number is the same number with BE in front: BE 0798.843.401.
Where is Dr Capucine Verstraete based?
The registered office is at Jules Van Biesbroeckstraat 2, 9050 Ghent.Company details
What does Dr Capucine Verstraete do?
According to the KBO register, the main activity is renting and operating of own or leased residential real estate, excluding social housing (NACE 68201).
What is the legal form of Dr Capucine Verstraete?
Dr Capucine Verstraete is a private limited company (BV).
When was Dr Capucine Verstraete founded?
Dr Capucine Verstraete was founded on 24-02-2023.
Is Dr Capucine Verstraete still active?
Yes, Dr Capucine Verstraete is an active enterprise in the KBO register.
What is the turnover of Dr Capucine Verstraete?
The turnover in financial year 2025 is about €220,000. This figure is estimated from the gross margin of €152,981 and 31 comparable companies (NACE 68201). It probably lies between €170,000 and €300,000.Financials
Is Dr Capucine Verstraete profitable?
In financial year 2025, Dr Capucine Verstraete made a profit of €100,798.
Where can I find the annual accounts of Dr Capucine Verstraete?
Dr Capucine Verstraete filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr Capucine Verstraete due?
Dr Capucine Verstraete must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.